Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19

Mostrar otras versiones (1)

Coronavirus disease-19 (COVID-19), resulting from infection with SARS-CoV-2, spans a wide spectrum of illness. In severely ill patients, highly elevated serum levels of certain cytokines and considerable cytolytic T cell infiltrates in the lungs have been observed. These same patients may bear low t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thoms, Brendan L., Gosselin, Jeanne, Libman, Bonita, Littenberg, Benjamin, Budd, Ralph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776555/
https://www.ncbi.nlm.nih.gov/pubmed/35079694
http://dx.doi.org/10.1007/s42399-022-01121-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776555/
https://www.ncbi.nlm.nih.gov/pubmed/35079694
http://dx.doi.org/10.1007/s42399-022-01121-4

Ejemplares similares